ici d8731 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cameron, NE; Cotter, MA; Dines, KC; Maxfield, EK | 1 |
| Hoenack, C; Roesen, P | 1 |
2 other study(ies) available for ici d8731 and Alloxan Diabetes
| Article | Year |
|---|---|
Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neural Conduction; Neurons, Afferent; Peripheral Nerves; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Regional Blood Flow; Sciatic Nerve | 1993 |
Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Biphenyl Compounds; Cell Membrane; Diabetes Mellitus, Experimental; Fosinopril; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Male; Membrane Proteins; Monosaccharide Transport Proteins; Muscle Proteins; Myocardium; Quinolines; Rats; Rats, Wistar | 1996 |